Sean Laaman

Stock Analyst at Morgan Stanley

(2.97)

# 1,278

Out of 4,814 analysts

2

Total ratings

100%

Success rate

54.92%

Average return

Main Sectors:

Top Industries:

Biotechnology Medical Instruments & Supplies

Stocks Rated by Sean Laaman

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ALEC Alector	Assumes: Underweight	$3 → $1.5	$0.93	+61.39%	1	Mar 7, 2025
	RMD ResMed	Upgrades: Overweight	$169	$211.49	-20.09%	1	Oct 27, 2023

Alector

Mar 7, 2025

Assumes: Underweight

Price Target: $3 → $1.5

Current: $0.93

Upside: +61.39%

ResMed

Oct 27, 2023

Upgrades: Overweight

Price Target: $169

Current: $211.49

Upside: -20.09%